Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:0874)
Hong Kong · Delayed Price · Currency is HKD 18.68
+0.08 (0.43%)
Jan 21, 2026, 2:49 PM HKT
HKG:0874 Market Cap
HKG:0874 has a market cap or net worth of 43.8 billion as of January 20, 2026. Its market cap has decreased by -6.90% in one year.
Market Cap
43.80B
Enterprise Value
43.63B
Revenue
84.74B
Ranking
n/a
PE Ratio
13.42
Stock Price
18.68
Market Cap Chart
Since February 6, 2001, HKG:0874's market cap has increased from 3.51B to 43.80B, an increase of 1,146.80%. That is a compound annual growth rate of 10.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 43.78B | -0.89% |
| Dec 31, 2025 | 44.17B | -5.06% |
| Dec 31, 2024 | 46.52B | -5.21% |
| Dec 29, 2023 | 49.08B | -6.35% |
| Dec 30, 2022 | 52.40B | -18.06% |
| Dec 31, 2021 | 63.96B | 20.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 164.43B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |